logo-loader
viewIntegumen

Integumen begins immediate production of Modern Water's monitoring bacteria reagent

Integumen PLC's (LON:SKIN) Gerry Brandon tells Proactive London's Andrew Scott they've begun production of Modern Water Plc's (LON:MWG) monitoring bacteria reagent six weeks ahead of schedule.

Brandon adds that the enlargement of their laboratories has also begun with the ordering of new equipment

Quick facts: Integumen

Price: 1.91 GBX

AIM:SKIN
Market: AIM
Market Cap: £20.54 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tiziana Life Sciences: Dr Weiner announces 'completely novel' approach to...

Harvard Medical School's Dr Howard Weiner, who's also chairman of Tiziana Life Sciences' (LON:TILS)(NASDAQ:TLSA) scientific advisory board, speaks to Proactive London's Andrew Scott after winning a competitive research grant from the NIH (National Institutes of Health) to investigate the drug's...

13 minutes ago

2 min read